Telomir Pharmaceuticals, Inc. (TELO) has 3 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 27, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 27, 2026 filed April 16, 2026 | Whalen Matthew Pratt Director | $0 | 50,000 | 0% | No | |
|
|
||||||
| July 27, 2026 filed April 16, 2026 | MacPherson Edward Clouston Director | $0 | 50,000 | 0% | No | |
|
|
||||||
| July 27, 2026 filed April 16, 2026 | Del Giudice Matthew Paul Director | $0 | 50,000 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free